<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Probiotics for preventing urinary tract infections in adults and children - Schwenger, EM - 2015 | Cochrane Library</title> <meta content="Probiotics for preventing urinary tract infections in adults and children - Schwenger, EM - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008772.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Probiotics for preventing urinary tract infections in adults and children - Schwenger, EM - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008772.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD008772.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Probiotics for preventing urinary tract infections in adults and children" name="citation_title"/> <meta content="Erin M Schwenger" name="citation_author"/> <meta content="University of British Columbia" name="citation_author_institution"/> <meta content="Aaron M Tejani" name="citation_author"/> <meta content="University of British Columbia" name="citation_author_institution"/> <meta content="Aaron.Tejani@ti.ubc.ca" name="citation_author_email"/> <meta content="Peter S Loewen" name="citation_author"/> <meta content="University of British Columbia" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD008772.pub2" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/12/23" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008772.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008772.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008772.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti‐Bacterial Agents [therapeutic use]; Bacterial Infections [*prevention &amp; control]; Probiotics [adverse effects, *therapeutic use]; Randomized Controlled Trials as Topic; Urinary Tract Infections [*prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008772.pub2&amp;doi=10.1002/14651858.CD008772.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="uQyIsxpV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD008772\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD008772\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008772\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008772\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ms","hr","pl","fa","th"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD008772.pub2",title:"Probiotics for preventing urinary tract infections in adults and children",firstPublishedDate:"Dec 23, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Kidney and Transplant Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uQyIsxpV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008772.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008772.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD008772.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD008772.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008772.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD008772.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD008772.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD008772.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD008772.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD008772.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>23636 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD008772.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/full#CD008772-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/full#CD008772-sec-0080"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/full#CD008772-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/full#CD008772-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/full#CD008772-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/full#CD008772-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/full#CD008772-sec-0052"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/full#CD008772-sec-0074"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/appendices#CD008772-sec-0085"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/table_n/CD008772StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/table_n/CD008772StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Probiotics for preventing urinary tract infections in adults and children</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/information#CD008772-cr-0002">Erin M Schwenger</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/information#CD008772-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>Aaron M Tejani</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008772.pub2/information#CD008772-cr-0004">Peter S Loewen</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/information/en#CD008772-sec-0089">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 23 December 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD008772.pub2">https://doi.org/10.1002/14651858.CD008772.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD008772-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008772-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008772-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008772-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/th#CD008772-abs-0012">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD008772-abs-0001" lang="en"> <section id="CD008772-sec-0001"> <h3 class="title" id="CD008772-sec-0001">Background</h3> <p>Urinary tract infection (UTI) is a common bacterial infection that can lead to significant morbidity including stricture, abscess formation, fistula, bacteraemia, sepsis, pyelonephritis and kidney dysfunction. Mortality rates are reported to be as high as 1% in men and 3% in women due to development of pyelonephritis. Because probiotic therapy is readily available without a prescription, a review of their efficacy in the prevention of UTI may aid consumers in making informed decisions about potential prophylactic therapy. Institutions and caregivers also need evidence‐based synopses of current evidence to make informed patient care decisions. </p> </section> <section id="CD008772-sec-0002"> <h3 class="title" id="CD008772-sec-0002">Objectives</h3> <p>Compared to placebo or no therapy, did probiotics (any formulation) provide a therapeutic advantage in terms of morbidity and mortality, when used to prevent UTI in susceptible patient populations? </p> <p>Compared to other prophylactic interventions, including drug and non‐drug measures (e.g. continuous antibiotic prophylaxis, topical oestrogen, cranberry juice), did probiotics (any formulation) provide a therapeutic advantage in terms of morbidity and mortality when used to prevent UTIs in susceptible patient populations? </p> </section> <section id="CD008772-sec-0003"> <h3 class="title" id="CD008772-sec-0003">Search methods</h3> <p>We searched the Cochrane Kidney and Transplant Specialised Register to 21 September 2015 through contact with the Trials' Search Co‐ordinator using search terms relevant to this review. </p> </section> <section id="CD008772-sec-0004"> <h3 class="title" id="CD008772-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) of susceptible patients (e.g. past history of UTI) or healthy people in which any strain, formulation, dose or frequency of probiotic was compared to placebo or active comparators were included. </p> </section> <section id="CD008772-sec-0005"> <h3 class="title" id="CD008772-sec-0005">Data collection and analysis</h3> <p>All RCTs and quasi‐RCTs (RCTs in which allocation to treatment was obtained by alternation, use of alternate medical records, date of birth or other predictable methods) looking at comparing probiotics to no therapy, placebo, or other prophylactic interventions were included. Summary estimates of effect were obtained using a random‐effects model, and results were expressed as risk ratios (RR) and their 95% confidence intervals (CI) for dichotomous outcomes. </p> </section> <section id="CD008772-sec-0006"> <h3 class="title" id="CD008772-sec-0006">Main results</h3> <p>We included nine studies that involved 735 people in this review. Four studies compared probiotic with placebo, two compared probiotic with no treatment, two compared probiotics with antibiotics in patients with UTI, and one study compared probiotic with placebo in healthy women. All studies aimed to measure differences in rates of recurrent UTI. </p> <p>Our risk of bias assessment found that most studies had small sample sizes and reported insufficient methodological detail to enable robust assessment. Overall, there was a high risk of bias in the included studies which lead to inability to draw firm conclusions and suggesting that any reported treatment effects may be misleading or represent overestimates. </p> <p>We found no significant reduction in the risk of recurrent symptomatic bacterial UTI between patients treated with probiotics and placebo (6 studies, 352 participants: RR 0.82, 95% CI 0.60 to 1.12; I<sup>2</sup> = 23%) with wide confidence intervals, and statistical heterogeneity was low. No significant reduction in the risk of recurrent symptomatic bacterial UTI was found between probiotic and antibiotic treated patients (1 study, 223 participants: RR 1.12, 95% CI 0.95 to 1.33). </p> <p>The most commonly reported adverse effects were diarrhoea, nausea, vomiting, constipation and vaginal symptoms. None of the included studies reported numbers of participants with at least one asymptomatic bacterial UTI, all‐cause mortality or those with at least one confirmed case of bacteraemia or fungaemia. Two studies reported study withdrawal due to adverse events and the number of participants who experienced at least one adverse event. One study reported withdrawal occurred in six probiotic participants (5.2%), 15 antibiotic participants (12.2%), while the second study noted one placebo group participant discontinued treatment due to an adverse event. </p> </section> <section id="CD008772-sec-0007"> <h3 class="title" id="CD008772-sec-0007">Authors' conclusions</h3> <p>No significant benefit was demonstrated for probiotics compared with placebo or no treatment, but a benefit cannot be ruled out as the data were few, and derived from small studies with poor methodological reporting. </p> <p>There was limited information on harm and mortality with probiotics and no evidence on the impact of probiotics on serious adverse events. Current evidence cannot rule out a reduction or increase in recurrent UTI in women with recurrent UTI who use prophylactic probiotics. There was insufficient evidence from one RCT to comment on the effect of probiotics versus antibiotics. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD008772-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008772-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD008772-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD008772-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008772-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD008772-abs-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD008772-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD008772-abs-0008">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD008772-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD008772-abs-0013">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD008772-abs-0003" lang="en"> <h3>Probiotics for preventing urinary tract infections in adults and children</h3> <p><b>Background</b> </p> <p>Urinary tract infections (UTIs) occur in kidneys, ureters, urethra or bladder. UTIs are one of the most common bacterial infections and can lead to other health problems. </p> <p>Probiotics (live micro‐organisms which, when administered in adequate amounts, confer a health benefit on the host) are thought to work by preventing other infectious bacteria from climbing up the urinary tract and causing infection. We were interested in studying any form of probiotics (bacteria used to change balance of bacteria) compared with no treatment, antibiotics, hormone therapy, cranberry juice or other interventions in people at risk of UTI. To assess if probiotics were effective, we planned to measure how many people had recurrent UTIs. </p> <p><b>Study characteristics</b> </p> <p>We conducted a literature search up to September 2015 and nine studies were eligible for inclusion according to our selection criteria. The nine studies reported data on 735 participants and investigated probiotics for preventing UTI: seven studies involved women or girls with recurrent UTIs, one looked at children with abnormal urinary tracts, and one investigated UTI in healthy women. </p> <p><b>Key results</b> </p> <p>Generally, studies were poor quality with high risk of bias. Aside from the different populations, there were also many different species of probiotics used, different dosage forms such as vaginal and oral, and probiotics were given for varying lengths of time. All of these factors may have affected our results. </p> <p>Most studies did not collect information on adverse effects so we were unable to estimate any harms associated with probiotic therapies. We found no significant reduction in the risk of recurrent symptomatic bacterial UTI between patients treated with probiotics and placebo and no significant reduction in the risk of recurrent symptomatic bacterial UTI was found between probiotic and patients treated with antibiotics. </p> <p><b>Quality of the evidence</b> </p> <p>The currently available evidence shows no reduction in UTI using probiotics.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD008772-sec-0080" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008772-sec-0080">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008772-sec-0116">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD008772-sec-0080"></div> <h3 class="title" id="CD008772-sec-0081">Implications for practice</h3> <section id="CD008772-sec-0081"> <p>There was insufficient evidence to determine whether or not probiotics reduce the risk of further UTIs in susceptible patient populations (e.g. previous history of UTI, women, school‐aged girls, men with enlarged prostates, and the elderly) compared with either placebo or antibiotic prophylaxis. This conclusion is limited by the generally high risk of bias in the small number of studies available, with limited reporting on harm, mortality and serious adverse events. </p> </section> <h3 class="title" id="CD008772-sec-0082">Implications for research</h3> <section id="CD008772-sec-0082"> <p>Larger well‐designed RCTs are necessary and should include recurrent symptomatic UTI as primary outcome. The potential for probiotics to reduce recurrent UTI in women and children with recently‐treated UTI compared to those without a recently‐treated UTI should be explored. Optimal probiotic agents, dosing and duration of therapy also remain to be determined. Studies should be placebo‐controlled or contain both a placebo and active antibiotic control group. Emphasis should be placed on the measurement of harm as well as development of recurrent UTI during follow‐up. We feel that until there is sufficient evidence that probiotics provide a therapeutic advantage over placebo, future studies should not focus on active comparators alone. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD008772-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD008772-sec-0022"></div> <div class="table" id="CD008772-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Probiotics compared with placebo or antibiotics for urinary tract infections (UTI)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: adults and children at risk of UTI</b> </p> <p><b>Settings: outpatient</b> </p> <p><b>Intervention: probiotics</b> </p> <p><b>Comparison: placebo or antibiotics</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probiotics</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic bacterial UTI in adults and children in patients with and without recurrent UTI</b> </p> <p><b>Probiotics versus placebo</b> </p> <p>(follow‐up)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>395 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>296 per 1000</b> <br/> (197 to 446) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR</b> 0.75 (0.50, 1.13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>352 (6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk of bias was assessed at unclear or high in most domains and suggest that results are imprecise or overestimate probiotic effects versus placebo </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic bacterial UTI in adults and children with recurrent UTI</b> </p> <p><b>Probiotics versus placebo</b> </p> <p>(follow‐up)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>421 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>315 per 1000</b> <br/> (227 to 425) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR</b> 0.74 (0.54, 1.01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>275 (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk of bias was assessed at unclear or high in most domains and suggest that results are imprecise or overestimate probiotic effects versus placebo </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic bacterial UTI in women with recent UTI</b> </p> <p><b>Probiotics versus antibiotics</b> </p> <p>(follow‐up)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>666 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>745 per 1000</b> <br/> (632 to 885) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR</b> 1.12 (0.95, 1.33) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>223 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk of bias was assessed at unclear or high in most domains and suggest that results are imprecise or overestimate probiotic effects versus antibiotics. </p> <p>Imprecision also due to small sample from only one RCT</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic bacterial UTI in children with VUR</b> </p> <p><b>Probiotics versus placebo</b> </p> <p>(follow‐up)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>270 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>145 per 1000</b> <br/> (64 to 332) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR</b> 0.54 (0.24, 1.23) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk of bias was assessed at unclear or high in most domains of and suggest that results are imprecise or overestimate probiotic effects versus placebo. </p> <p>Imprecision also due to small sample from only one RCT</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>UTi ‐ urinary tract infection</p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD008772-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008772-sec-0023">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008772-sec-0096">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD008772-sec-0023"></div> <section id="CD008772-sec-0024"> <h3 class="title" id="CD008772-sec-0024">Description of the condition</h3> <p>Urinary tract infections (UTIs) are defined as infections of kidneys, ureters, urethra, or bladder due to bacterial colonisation. UTIs are one of the most common bacterial infections and can lead to significant morbidity including strictures, abscess formation, fistulas, bacteraemia, sepsis, pyelonephritis, and kidney dysfunction. Mortality rates are reported to be as high as 1% in men and 3% in women due to development of pyelonephritis. One in two women experience UTI at some point in their lifetime. UTI incidence in men is related to age (1.1% to 1.6% in the first 10 years of life, 5 to 8 infections/year/10,000 men up to age 50 years, and higher after age 50 due to prostate enlargement and subsequent complications) (<a href="./references#CD008772-bbs2-0027" title="FoxmanB . Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Disease‐a‐Month2003;49(2):53‐70. [MEDLINE: 12601337] ">Foxman 2003</a>, <a href="./references#CD008772-bbs2-0033" title="HowesDS . Urinary tract infections, female. emedicine.medscape.com/article/778670‐overview(accessed August 2010). ">Howes 2009</a>; <a href="./references#CD008772-bbs2-0034" title="HowesDS , PillowMT . Urinary tract infections, male. emedicine.medscape.com/article/778578‐overview(accessed August 2010). ">Howes 2010</a>). Elderly people are more susceptible to asymptomatic UTI; prevalence is 30% in women and 10% in men per year in women and men (<a href="./references#CD008772-bbs2-0041" title="RichardsCL . Urinary tract infections in the frail elderly: Issues for diagnosis, treatment and prevention. International Urology &amp; Nephrology2004;36(3):457‐63. [MEDLINE: 15783124] ">Richards 2004</a>). </p> <p>Several interventions have been studied for preventing UTI. Mixed results have been seen for intravaginal hormonal therapy for women and management of incontinence (<a href="./references#CD008772-bbs2-0039" title="PerrottaC , AznarM , MejiaR , AlbertX , NgCW . Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database of Systematic Reviews2008, Issue 2. [DOI: 10.1002/14651858.CD005131.pub2] ">Perrotta 2008</a>; <a href="./references#CD008772-bbs2-0038" title="OuslanderJG , SchnelleJF , UmanG , FingoldS , NigamJG , TuicoE , et al. Predictors of successful prompted voiding among incontinent nursing home residents. JAMA1995;273(17):1366‐70. [MEDLINE: 7715062] ">Ouslander 1995</a>; <a href="./references#CD008772-bbs2-0043" title="SchnelleJF , McNeesP , CrooksV , OuslanderJG . The use of a computer‐based model to implement an incontinence management program. Gerontologist1995;35(5):656‐65. [MEDLINE: 8543223] ">Schnelle 1995</a>). Improved urinary catheter technology and catheter management strategies have demonstrated efficacy in reducing UTI incidence (<a href="./references#CD008772-bbs2-0024" title="Centers for Disease Control and Prevention (CDC). Monitoring hospital‐acquired infections to promote patient safety‐‐United States, 1990‐1999.[Erratum appears in MMWR Morb Mortal Wkly Rep 2000 Mar 10;49(9):189‐90]. MMWR ‐ Morbidity &amp; Mortality Weekly Report2000;49(8):149‐53. [MEDLINE: 10737441] ">CDC 2000</a>; <a href="./references#CD008772-bbs2-0025" title="ChristensenJ , JepsenOB . Reduced rates of hospital acquired UTI in medical patients. Prevalence surveys indicate effect of active infection control programmes. Journal of Hospital Infection2001;47(1):36‐40. [MEDLINE: 11161896] ">Christensen 2001</a>; <a href="./references#CD008772-bbs2-0036" title="MakiD , TambyahPA . Engineering out the risk of infection with urinary catheters. Emerging Infectious Diseases2001;7(2):342‐7. [MEDLINE: 11294737] ">Maki 2001</a>; <a href="./references#CD008772-bbs2-0040" title="RichardsC , EmoriTG , PeavyG , GaynesRP . Promoting quality through measurement of performance and response: prevention success stories. Emerging Infectious Diseases2001;7(2):299‐301. [MEDLINE: 11294728] ">Richards 2001</a>; <a href="./references#CD008772-bbs2-0042" title="SaintS , WieseJ , AmoryJK , BernsteinML , PatelUD , ZemencukJK , et al. Are physicians aware of which of their patients have indwelling urinary catheters?. American Journal of Medicine2000;109(6):476‐80. [MEDLINE: 11042237] ">Saint 2000</a>). A systematic review of randomised controlled trials (RCTs) concluded that there is some evidence that cranberry juice reduces the incidence of UTIs in women (<a href="./references#CD008772-bbs2-0035" title="JepsonRG , WilliamsG , CraigJC . Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews2012, Issue 10. [DOI: 10.1002/14651858.CD001321.pub5] ">Jepson 2012</a>). Prophylactic antibiotics have been shown to reduce the incidence of UTIs in non‐pregnant women with recurrent UTIs (<a href="./references#CD008772-bbs2-0022" title="AlbertX , HuertasI , PereiróI , SanfélixJ , GosalbesV , PerrottaC . Antibiotics for preventing recurrent urinary tract infection in non‐pregnant women. Cochrane Database of Systematic Reviews2004, Issue 3. [DOI: 10.1002/14651858.CD001209.pub2] ">Albert 2004</a>) and may reduce asymptomatic UTIs in children (<a href="./references#CD008772-bbs2-0046" title="WilliamsG , CraigJC . Long‐term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database of Systematic Reviews2011, Issue 3. [DOI: 10.1002/14651858.CD001534.pub3] ">Williams 2011</a>). </p> </section> <section id="CD008772-sec-0025"> <h3 class="title" id="CD008772-sec-0025">Description of the intervention</h3> <p>Probiotics are defined as "a preparation of, or a product containing viable, defined micro‐organisms in sufficient numbers, which alter the microflora (by implantation or colonisation) in a compartment of the host and by that exert beneficial health effects in this host" (<a href="./references#CD008772-bbs2-0044" title="SchrezenmeirJ , deVreseM . Probiotics, prebiotics, and synbiotics ‐ approaching a definition. American Journal of Clinical Nutrition2001;73(2 Suppl):361S‐364S. [MEDLINE: 11157342] ">Schrezenmeir 2001</a>). There are a number of species and strains of probiotics available that are used in many formulations administered via several different routes. </p> </section> <section id="CD008772-sec-0026"> <h3 class="title" id="CD008772-sec-0026">How the intervention might work</h3> <p>Probiotic organisms (e.g. lactobacillus) are thought to establish a barrier against infectious pathogens ascending the urinary tract, colonising, and subsequently causing infection. The protective effects thought to be exerted by probiotics are thought to include reducing pathogen adherence, growth and colonisation, and modulating host defences (<a href="./references#CD008772-bbs2-0023" title="BruceAW , ReidG . Intravaginal instillation of lactobacilli for the prevention of recurrent urinary tract infections. Canadian Journal of Microbiology1988;34(3):339‐43. [MEDLINE: 3138016] ">Bruce 1988</a>; <a href="./references#CD008772-bbs2-0029" title="HawthornLA , ReidG . Exclusion of uropathogen adhesion to polymer surfaces by Lactobacillus acidophilus. Journal of Biomedical Materials Research1990;24(1):39‐46. [MEDLINE: 2105962] ">Hawthorn 1990</a>; <a href="./references#CD008772-bbs2-0030" title="HeinemannC , vanHylckama VliegJE , JanssenDB , BusscherHJ , van derMeiHC , ReidG . Purification and characterization of a surface‐binding protein from Lactobacillus fermentum RC‐14 that inhibits adhesion of Enterococcus faecalis 1131. FEMS Microbiology Letters2000;190(1):177‐80. [MEDLINE: 10981710] ">Heineman 2000</a>; <a href="./references#CD008772-bbs2-0037" title="OssetJ , BartolomeRM , GarciaE , AndreuA . Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. Journal of Infectious Diseases2001;183(3):485‐91. [MEDLINE: 11133381] ">Osset 2001</a>; <a href="./references#CD008772-bbs2-0045" title="VelraedsMM , van deBelt‐GritterB , van derMeiHC , ReidG , BusscherHJ . Interference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus biosurfactant. Journal of Medical Microbiology1998;47(12):1081‐5. [MEDLINE: 9856644] ">Velraeds 1998</a>). </p> </section> <section id="CD008772-sec-0027"> <h3 class="title" id="CD008772-sec-0027">Why it is important to do this review</h3> <p>A 2006 systematic review concluded that carefully selected strains of probiotics when tested in case‐control studies and RCTs had mixed effects in terms of UTI prophylaxis (<a href="./references#CD008772-bbs2-0026" title="FalagasME , BetsiGI , AthanasiouS . Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. Journal of Antimicrobial Chemotherapy2006;58(2):266‐72. [MEDLINE: 16790461] ">Falagas 2006</a>). The authors concluded that there was some in vitro and in vivo evidence that probiotics restore normal vaginal flora and prevent recurrent UTI in women (<a href="./references#CD008772-bbs2-0026" title="FalagasME , BetsiGI , AthanasiouS . Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. Journal of Antimicrobial Chemotherapy2006;58(2):266‐72. [MEDLINE: 16790461] ">Falagas 2006</a>). </p> <p>Probiotic therapy is readily available without prescription. A review of their efficacy in preventing UTIs may aid consumers and healthcare providers to make informed decisions about potential prophylactic therapy. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD008772-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008772-sec-0028">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008772-sec-0101">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD008772-sec-0028"></div> <p>Our review aimed to assess:</p> <p> <ol id="CD008772-list-0001"> <li> <p>Compared to placebo or no therapy, do probiotics (any formulation) provide a therapeutic advantage in terms of morbidity and mortality, when used to prevent UTIs in susceptible patient populations? </p> </li> <li> <p>Compared to other prophylactic interventions, including drug and non‐drug measures (e.g. continuous antibiotic prophylaxis, topical oestrogen, cranberry juice), do probiotics (any formulation) provide a therapeutic advantage in terms of morbidity and mortality when used to prevent UTIs in susceptible patient populations? </p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD008772-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008772-sec-0029">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008772-sec-0102">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD008772-sec-0029"></div> <section id="CD008772-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD008772-sec-0031"> <h4 class="title">Types of studies</h4> <p>All RCTs and quasi‐RCTs (RCTs in which allocation to treatment was obtained by alternation, use of alternate medical records, date of birth or other predictable methods) looking at comparing probiotics to no therapy, placebo, or other prophylactic interventions were included. </p> </section> <section id="CD008772-sec-0032"> <h4 class="title">Types of participants</h4> <p> <ul id="CD008772-list-0002"> <li> <p>Men, women, and children with histories of recurrent bacterial UTI (two episodes within the last two months) </p> </li> <li> <p>Men and women over the age of 60 years</p> </li> <li> <p>Pregnant women</p> </li> <li> <p>Men, women and children with an indwelling catheter or requiring intermittent catheterisation</p> </li> <li> <p>Men, women and children with an abnormal urinary tract (for example vesicoureteric reflux, urinary obstruction, dysfunctional voiding) </p> </li> <li> <p>Men and women resident in residential and long‐term care facilities</p> </li> <li> <p>Men and women with asymptomatic bacteriuria.</p> </li> </ul> </p> <p>Studies exclusively involving critically ill or immunosuppressed patients were excluded. Applicable patient data were extracted from studies with mixed populations. </p> </section> <section id="CD008772-sec-0033"> <h4 class="title">Types of interventions</h4> <p> <ul id="CD008772-list-0003"> <li> <p>All available probiotics in any formulation including tablets, capsules, food products (i.e. shakes, yogurt) for preventing UTIs in adults and children. </p> </li> <li> <p>Any study in which probiotics were used for the treatment (versus prevention) of suspected or proven bacterial UTI was excluded. </p> </li> <li> <p>Studies investigating prophylaxis with probiotics in combination with antibiotics were not included. These topics were beyond the scope of this review. </p> </li> </ul> </p> </section> <section id="CD008772-sec-0034"> <h4 class="title">Types of outcome measures</h4> <section id="CD008772-sec-0035"> <h5 class="title">Primary outcomes</h5> <p>Numbers of patients with at least one symptomatic bacterial UTI in each group (as confirmed by a catheter specimen of urine, midstream urine specimen if possible, or a clean catch specimen and defined as &gt; 10<sup>5</sup> CFU/mL, or as defined by authors).  </p> </section> <section id="CD008772-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD008772-list-0004"> <li> <p>Numbers with at least one asymptomatic bacterial UTI (confirmed by a catheter specimen of urine, midstream urine specimen if possible, or a clean catch specimen) </p> </li> <li> <p>Withdrawal due to adverse events</p> </li> <li> <p>Total adverse events</p> </li> <li> <p>All‐cause mortality</p> </li> <li> <p>Numbers with at least one non‐fatal serious adverse events</p> </li> <li> <p>Numbers with at least one confirmed case of bacteraemia or fungaemia.</p> </li> </ul> </p> </section> </section> </section> <section id="CD008772-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD008772-sec-0038"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Kidney and Transplant Specialised Register to 21 September 2015 through contact with the Trials' Search Co‐ordinator using search terms relevant to this review. The Specialised Register contains studies identified from several sources. </p> <p> <ol id="CD008772-list-0005"> <li> <p>Monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL)</p> </li> <li> <p>Weekly searches of MEDLINE OVID SP</p> </li> <li> <p>Handsearching of kidney‐related journals and the proceedings of major kidney conferences</p> </li> <li> <p>Searching of the current year of EMBASE OVID SP</p> </li> <li> <p>Weekly current awareness alerts for selected kidney journals</p> </li> <li> <p>Searches of the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov.</p> </li> </ol> </p> <p>Studies contained in the Specialised Register are identified through search strategies for CENTRAL, MEDLINE, and EMBASE based on the scope of Cochrane Kidney and Transplant. Details of these strategies, as well as a list of handsearched journals, conference proceedings and current awareness alerts, are available in the Specialised Register section of information about the <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/RENAL/frame.html" target="_blank">Cochrane Kidney and Transplant</a>. </p> <p>See <a href="./appendices#CD008772-sec-0086">Appendix 1</a> for search terms. </p> </section> <section id="CD008772-sec-0039"> <h4 class="title">Searching other resources</h4> <p> <ol id="CD008772-list-0006"> <li> <p>Reference lists of review articles, relevant studies and clinical practice guidelines.</p> </li> <li> <p>Letters seeking information about unpublished or incomplete studies to investigators known to be involved in previous studies. </p> </li> </ol> </p> </section> </section> <section id="CD008772-sec-0040"> <h3 class="title" id="CD008772-sec-0040">Data collection and analysis</h3> <section id="CD008772-sec-0041"> <h4 class="title">Selection of studies</h4> <p>The search strategy described was used to obtain titles and abstracts of studies relevant to the review. Titles and abstracts were screened independently by two authors, who discarded studies that were not applicable; however studies and reviews that potentially included relevant data or information on studies were retained initially. Two authors independently assessed retrieved abstracts and where necessary, the full text of these studies to determine which satisfied inclusion criteria. There were no language restrictions. </p> </section> <section id="CD008772-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>Data extraction was carried out independently by two authors using standard data extraction forms. Studies reported in non‐English language journals were to be translated before assessment. Where more than one publication of one study existed, reports were grouped together and the publication with the most complete data was used in the analyses. Where relevant outcomes were only published in earlier versions these data were used. Any discrepancies among published versions was planned to be highlighted. </p> </section> <section id="CD008772-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The following items were independently assessed by two authors using the risk of bias assessment tool (<a href="./references#CD008772-bbs2-0032" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) (see <a href="./appendices#CD008772-sec-0087">Appendix 2</a>). </p> <p> <ul id="CD008772-list-0007"> <li> <p>Was there adequate sequence generation (selection bias)?</p> </li> <li> <p>Was allocation adequately concealed (selection bias)?</p> </li> <li> <p>Was knowledge of the allocated interventions adequately prevented during the study?</p> <ul id="CD008772-list-0008"> <li> <p>Participants and personnel (performance bias)</p> </li> <li> <p>Outcome assessors (detection bias)</p> </li> </ul> </li> <li> <p>Were incomplete outcome data adequately addressed (attrition bias)?</p> </li> <li> <p>Are reports of the study free of suggestion of selective outcome reporting (reporting bias)? </p> </li> <li> <p>Was the study apparently free of other problems that could put it at a risk of bias?</p> </li> </ul> </p> </section> <section id="CD008772-sec-0044"> <h4 class="title">Measures of treatment effect</h4> <p>Dichotomous outcomes results were expressed as risk ratio (RR) with 95% confidence intervals (CI). All prespecified outcomes were dichotomous; therefore no analysis of continuous outcome data was necessary. </p> </section> <section id="CD008772-sec-0045"> <h4 class="title">Unit of analysis issues</h4> <p>Data from all patients individually randomised to each intervention were included in the analyses. Care was taken to identify situations in which data had been censored or excluded or if data presented were the total number of events or the total number of patients with a first event. Authors were contacted for clarification if necessary. The rates of each outcome in the probiotic groups group were compared to the rate of that outcome in control groups to calculate risk differences. If the rates for an outcome were not provided, a narrative summary of data was presented. UTI rates were extracted for numbers of patients experiencing at least one UTI, not the number of UTIs in a treatment group. </p> </section> <section id="CD008772-sec-0046"> <h4 class="title">Dealing with missing data</h4> <p>In general if there were missing data, the authors of the study were contacted for clarification to determine if details were available. If not, or if authors did not respond to requests, the worst outcome was imputed for all missing data points in the experimental treatment group (i.e. worst case scenario). A sensitivity analysis was performed to see if the effect size for any particular outcome was sensitive to conducting the worst case scenario with imputed data versus ignoring the missing data (i.e. using only the available data). </p> </section> <section id="CD008772-sec-0047"> <h4 class="title">Assessment of heterogeneity</h4> <p>Heterogeneity was analysed using a Chi<sup>2</sup> test on N‐1 degrees of freedom, with an alpha of 0.05 used for statistical significance and with the I<sup>2</sup> test (<a href="./references#CD008772-bbs2-0031" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [MEDLINE: 12958120] ">Higgins 2003</a>). I<sup>2</sup> values of 25%, 50% and 75% correspond to low, medium and high levels of heterogeneity.  </p> </section> <section id="CD008772-sec-0048"> <h4 class="title">Assessment of reporting biases</h4> <p>A funnel plot was not created because of the few included studies; the resulting analysis would likely be underpowered to detect possible publication bias (<a href="./references#CD008772-bbs2-0032" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD008772-sec-0049"> <h4 class="title">Data synthesis</h4> <p>Data were pooled using relative risks with the random‐effects model.</p> </section> <section id="CD008772-sec-0050"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Subgroup analyses were conducted for studies comparing probiotics with placebo or active comparators. In addition, a post‐hoc subgroup analysis was conducted for different patient characteristics: adult women; children, and children with vesicoureteral reflux. </p> </section> <section id="CD008772-sec-0051"> <h4 class="title">Sensitivity analysis</h4> <p>Sensitivity analysis was performed to test for robustness of the results. Analysis of the following categories was undertaken separately. </p> <p> <ol id="CD008772-list-0009"> <li> <p>Studies without proper randomisation or concealment of allocation compared to those without these characteristics. </p> </li> <li> <p>Studies performed without intention‐to‐treat (ITT) analysis compared to those with an ITT analysis. </p> </li> <li> <p>Unblinded studies versus blinded studies.</p> </li> <li> <p>Studies using different probiotic formulations.</p> </li> <li> <p>The effects of probiotics when there is missing data for patients receiving probiotics, these patients are assumed to have had the worst possible outcome. </p> </li> </ol> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD008772-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD008772-sec-0052"></div> <section id="CD008772-sec-0053"> <h3 class="title">Description of studies</h3> <section id="CD008772-sec-0054"> <h4 class="title">Results of the search</h4> <p>We identified 389 records. Following assessment of titles and abstracts, 28 full‐text records were screened. Of these, nine studies (14 records) were included and eight studies (10 records) were excluded. Two ongoing studies were identified (<a href="./references#CD008772-bbs2-0020" title="NCT00781625 . Probiotics/lactobacillus as a prophylactic aid in recurrent bacterial cystitis in women. a randomized, prospective, double‐blinded, placebo controlled, multi‐center study. www.clinicaltrials.gov/ct2/show/NCT00781625 (accessed 21 September 2015). ">NCT00781625</a>; <a href="./references#CD008772-bbs2-0021" title="TohSL , LeeBS , RyanS , SimpsonJ . Prophylaxis of spinal cord injury urinary tract infection therapeutic trial (ProSCIUTTU): protocol [abstract]. 53rd ISCoS Annual Scientific Meeting; 2014 Sept 2‐4; Maastricht, Netherlands. 2014. ">ProSCIUTTU Study 2014</a>), one study is awaiting translation (<a href="./references#CD008772-bbs2-0019" title="SkerkV , FerincevicR , MarkoticA , AndrasevicS , MilosevicV , VargovicM , et al. Research on the efficacy of prophylactic use of Acidosalus probiotic in women with recurrent cystitis [Ispitivanje djelotvornosti profilakticke primjene probiotika Acidosalus u zena s rekurentnim cistitisom]. Infektoloski Glasnik2010;30(1):21‐5. [EMBASE: 2010599396] ">Skerk 2010</a>), and one study was identified prior to publication ( <a href="./references#CD008772-bbs2-0018" title="ReidG , BruceAW , TaylorM . Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecology &amp; Therapy1995;23:32‐45. ">Reid 1995</a>). These four studies and will be assessed in a future update of this review (<a href="#CD008772-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD008772-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD008772-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD008772-sec-0055"> <h4 class="title">Included studies</h4> <p>We included nine studies in this review (<a href="./references#CD008772-bbs2-0001" title="BaerheimA , LarsenE , DigranesA . Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scandinavian Journal of Primary Health Care1994;12(4):239‐43. [MEDLINE: 7863140] ">Baerheim 1994</a>; <a href="./references#CD008772-bbs2-0002" title="CzajaCA , StapletonAE , Yarova‐YarovayaY , StammWE . Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infectious Diseases in Obstetrics &amp; Gynecology2007;2007:35387. [MEDLINE: 18288237] ">Czaja 2007</a>; <a href="./references#CD008772-bbs2-0003" title="FerraraP , RomanielloL , VitelliO , GattoA , ServaM , CataldiL . Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scandinavian Journal of Urology &amp; Nephrology2009;43(5):369‐72. [MEDLINE: 19921981] ">Ferrara 2009</a>; <a href="./references#CD008772-bbs2-0004" title="KontiokariT , SundqvistK , NuutinenM , PokkaT , KoskelaM , UhariM . Randomised trial of cranberry‐lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ2001;322(7302):1‐5. [MEDLINE: 11431298] ">Kontiokari 2001</a>; <a href="./references#CD008772-bbs2-0005" title="LeeSJ , KimHJ , ShimYH , LeeJW . The effect of probiotic prophylaxis for preventing recurrent urinary tract infection in children with persistent primary vesicoureteral reflux [abstract no: COD. PP 81]. Pediatric Nephrology2006;21(10):1542. [CENTRAL: CN‐00724966] LeeSJ , ShimYH , ChoSJ , LeeJW . Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatric Nephrology2007;22(9):1315‐20. [MEDLINE: 17530295] ">Lee 2007a</a>; <a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a>; <a href="./references#CD008772-bbs2-0007" title="ReidG , BruceAW , TaylorM . Influence of three‐day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clinical Therapeutics1992;14(1):11‐6. [MEDLINE: 1576619] ">Reid 1992</a>; <a href="./references#CD008772-bbs2-0008" title="ReidG , CharbonneauD , ErbJ , KochanowskiB , BeuermanD , PoehnerR , et al. Oral use of Lactobacillus rhamnosus GR‐1 and L. fermentum RC‐14 significantly alters vaginal flora: randomized, placebo‐controlled trial in 64 healthy women. FEMS Immunology &amp; Medical Microbiology2003;35(2):131‐4. [MEDLINE: 12628548] ">Reid 2003</a>; <a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a>). </p> <p>Six studies compared probiotics with placebo (<a href="./references#CD008772-bbs2-0001" title="BaerheimA , LarsenE , DigranesA . Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scandinavian Journal of Primary Health Care1994;12(4):239‐43. [MEDLINE: 7863140] ">Baerheim 1994</a>; <a href="./references#CD008772-bbs2-0002" title="CzajaCA , StapletonAE , Yarova‐YarovayaY , StammWE . Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infectious Diseases in Obstetrics &amp; Gynecology2007;2007:35387. [MEDLINE: 18288237] ">Czaja 2007</a>; <a href="./references#CD008772-bbs2-0007" title="ReidG , BruceAW , TaylorM . Influence of three‐day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clinical Therapeutics1992;14(1):11‐6. [MEDLINE: 1576619] ">Reid 1992</a>; <a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a>) or no comparator (<a href="./references#CD008772-bbs2-0003" title="FerraraP , RomanielloL , VitelliO , GattoA , ServaM , CataldiL . Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scandinavian Journal of Urology &amp; Nephrology2009;43(5):369‐72. [MEDLINE: 19921981] ">Ferrara 2009</a>; <a href="./references#CD008772-bbs2-0004" title="KontiokariT , SundqvistK , NuutinenM , PokkaT , KoskelaM , UhariM . Randomised trial of cranberry‐lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ2001;322(7302):1‐5. [MEDLINE: 11431298] ">Kontiokari 2001</a>); two studies compared probiotics with antibiotic prophylaxis in patients with UTI (one in adults (<a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a>) and one in children with VUR (<a href="./references#CD008772-bbs2-0005" title="LeeSJ , KimHJ , ShimYH , LeeJW . The effect of probiotic prophylaxis for preventing recurrent urinary tract infection in children with persistent primary vesicoureteral reflux [abstract no: COD. PP 81]. Pediatric Nephrology2006;21(10):1542. [CENTRAL: CN‐00724966] LeeSJ , ShimYH , ChoSJ , LeeJW . Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatric Nephrology2007;22(9):1315‐20. [MEDLINE: 17530295] ">Lee 2007a</a>)); and one study compared probiotics with placebo in healthy women (<a href="./references#CD008772-bbs2-0008" title="ReidG , CharbonneauD , ErbJ , KochanowskiB , BeuermanD , PoehnerR , et al. Oral use of Lactobacillus rhamnosus GR‐1 and L. fermentum RC‐14 significantly alters vaginal flora: randomized, placebo‐controlled trial in 64 healthy women. FEMS Immunology &amp; Medical Microbiology2003;35(2):131‐4. [MEDLINE: 12628548] ">Reid 2003</a>). </p> <section id="CD008772-sec-0056"> <h5 class="title">Design</h5> <p>The included studies were parallel RCTs with a mix of active comparators, placebo or no comparators. Efficacy of the probiotics in placebo‐controlled studies (<a href="./references#CD008772-bbs2-0001" title="BaerheimA , LarsenE , DigranesA . Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scandinavian Journal of Primary Health Care1994;12(4):239‐43. [MEDLINE: 7863140] ">Baerheim 1994</a>; <a href="./references#CD008772-bbs2-0002" title="CzajaCA , StapletonAE , Yarova‐YarovayaY , StammWE . Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infectious Diseases in Obstetrics &amp; Gynecology2007;2007:35387. [MEDLINE: 18288237] ">Czaja 2007</a>; <a href="./references#CD008772-bbs2-0003" title="FerraraP , RomanielloL , VitelliO , GattoA , ServaM , CataldiL . Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scandinavian Journal of Urology &amp; Nephrology2009;43(5):369‐72. [MEDLINE: 19921981] ">Ferrara 2009</a>; <a href="./references#CD008772-bbs2-0004" title="KontiokariT , SundqvistK , NuutinenM , PokkaT , KoskelaM , UhariM . Randomised trial of cranberry‐lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ2001;322(7302):1‐5. [MEDLINE: 11431298] ">Kontiokari 2001</a>; <a href="./references#CD008772-bbs2-0007" title="ReidG , BruceAW , TaylorM . Influence of three‐day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clinical Therapeutics1992;14(1):11‐6. [MEDLINE: 1576619] ">Reid 1992</a>; <a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a>) could not be compared to studies that used effective prophylactic measures such as antibiotics (<a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a>). Placebo‐controlled studies were therefore analysed separately from active comparator studies. The 'no comparator' arms of the <a href="./references#CD008772-bbs2-0004" title="KontiokariT , SundqvistK , NuutinenM , PokkaT , KoskelaM , UhariM . Randomised trial of cranberry‐lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ2001;322(7302):1‐5. [MEDLINE: 11431298] ">Kontiokari 2001</a> and <a href="./references#CD008772-bbs2-0003" title="FerraraP , RomanielloL , VitelliO , GattoA , ServaM , CataldiL . Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scandinavian Journal of Urology &amp; Nephrology2009;43(5):369‐72. [MEDLINE: 19921981] ">Ferrara 2009</a> studies were used to include them with the four studies comparing probiotics with placebo. </p> <p>Based on <a href="./references#CD008772-bbs2-0035" title="JepsonRG , WilliamsG , CraigJC . Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews2012, Issue 10. [DOI: 10.1002/14651858.CD001321.pub5] ">Jepson 2012</a>, it appears that cranberry juice cannot be recommended for the prevention of UTI due to small effect sizes and studies with significant biases that limit the reliability of the data. There is also no identified evidence that lingonberry juice alone or in combination with cranberry juice has proven efficacy or safety versus placebo for the prevention of UTI. It is for this reason that probiotics were not compared versus cranberry juice (<a href="./references#CD008772-bbs2-0003" title="FerraraP , RomanielloL , VitelliO , GattoA , ServaM , CataldiL . Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scandinavian Journal of Urology &amp; Nephrology2009;43(5):369‐72. [MEDLINE: 19921981] ">Ferrara 2009</a>) or cranberry‐lingonberry juice (<a href="./references#CD008772-bbs2-0004" title="KontiokariT , SundqvistK , NuutinenM , PokkaT , KoskelaM , UhariM . Randomised trial of cranberry‐lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ2001;322(7302):1‐5. [MEDLINE: 11431298] ">Kontiokari 2001</a>). </p> </section> <section id="CD008772-sec-0057"> <h5 class="title">Sample sizes</h5> <p>The smallest study included 30 participants (<a href="./references#CD008772-bbs2-0002" title="CzajaCA , StapletonAE , Yarova‐YarovayaY , StammWE . Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infectious Diseases in Obstetrics &amp; Gynecology2007;2007:35387. [MEDLINE: 18288237] ">Czaja 2007</a>) and the largest 252 participants (<a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a>). Most studies (60%) included 100 participants or fewer (<a href="./references#CD008772-bbs2-0001" title="BaerheimA , LarsenE , DigranesA . Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scandinavian Journal of Primary Health Care1994;12(4):239‐43. [MEDLINE: 7863140] ">Baerheim 1994</a>; <a href="./references#CD008772-bbs2-0002" title="CzajaCA , StapletonAE , Yarova‐YarovayaY , StammWE . Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infectious Diseases in Obstetrics &amp; Gynecology2007;2007:35387. [MEDLINE: 18288237] ">Czaja 2007</a>; <a href="./references#CD008772-bbs2-0003" title="FerraraP , RomanielloL , VitelliO , GattoA , ServaM , CataldiL . Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scandinavian Journal of Urology &amp; Nephrology2009;43(5):369‐72. [MEDLINE: 19921981] ">Ferrara 2009</a>; <a href="./references#CD008772-bbs2-0007" title="ReidG , BruceAW , TaylorM . Influence of three‐day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clinical Therapeutics1992;14(1):11‐6. [MEDLINE: 1576619] ">Reid 1992</a>; <a href="./references#CD008772-bbs2-0008" title="ReidG , CharbonneauD , ErbJ , KochanowskiB , BeuermanD , PoehnerR , et al. Oral use of Lactobacillus rhamnosus GR‐1 and L. fermentum RC‐14 significantly alters vaginal flora: randomized, placebo‐controlled trial in 64 healthy women. FEMS Immunology &amp; Medical Microbiology2003;35(2):131‐4. [MEDLINE: 12628548] ">Reid 2003</a>; <a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a>). </p> </section> <section id="CD008772-sec-0058"> <h5 class="title">Setting</h5> <p>All nine studies took place in outpatient settings.</p> </section> <section id="CD008772-sec-0059"> <h5 class="title">Participants</h5> <p>Patient populations differed in terms of time since the last acute UTI and previous use of prophylactic antibiotics. Only <a href="./references#CD008772-bbs2-0008" title="ReidG , CharbonneauD , ErbJ , KochanowskiB , BeuermanD , PoehnerR , et al. Oral use of Lactobacillus rhamnosus GR‐1 and L. fermentum RC‐14 significantly alters vaginal flora: randomized, placebo‐controlled trial in 64 healthy women. FEMS Immunology &amp; Medical Microbiology2003;35(2):131‐4. [MEDLINE: 12628548] ">Reid 2003</a> included exclusively healthy women. Three studies required participants with acute UTI at inclusion to be treated before commencing the study (<a href="./references#CD008772-bbs2-0003" title="FerraraP , RomanielloL , VitelliO , GattoA , ServaM , CataldiL . Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scandinavian Journal of Urology &amp; Nephrology2009;43(5):369‐72. [MEDLINE: 19921981] ">Ferrara 2009</a>; <a href="./references#CD008772-bbs2-0004" title="KontiokariT , SundqvistK , NuutinenM , PokkaT , KoskelaM , UhariM . Randomised trial of cranberry‐lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ2001;322(7302):1‐5. [MEDLINE: 11431298] ">Kontiokari 2001</a>; <a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a>), <a href="./references#CD008772-bbs2-0008" title="ReidG , CharbonneauD , ErbJ , KochanowskiB , BeuermanD , PoehnerR , et al. Oral use of Lactobacillus rhamnosus GR‐1 and L. fermentum RC‐14 significantly alters vaginal flora: randomized, placebo‐controlled trial in 64 healthy women. FEMS Immunology &amp; Medical Microbiology2003;35(2):131‐4. [MEDLINE: 12628548] ">Reid 2003</a> randomised women to acute antibiotic therapy before randomising them to prophylaxis; and three studies listed acute UTI or recent antibiotic use as exclusion criteria (<a href="./references#CD008772-bbs2-0001" title="BaerheimA , LarsenE , DigranesA . Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scandinavian Journal of Primary Health Care1994;12(4):239‐43. [MEDLINE: 7863140] ">Baerheim 1994</a>; <a href="./references#CD008772-bbs2-0002" title="CzajaCA , StapletonAE , Yarova‐YarovayaY , StammWE . Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infectious Diseases in Obstetrics &amp; Gynecology2007;2007:35387. [MEDLINE: 18288237] ">Czaja 2007</a>; <a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a>). The study in children with VUR included children with persistent primary VUR following 12 months of antibiotic prophylaxis (<a href="./references#CD008772-bbs2-0005" title="LeeSJ , KimHJ , ShimYH , LeeJW . The effect of probiotic prophylaxis for preventing recurrent urinary tract infection in children with persistent primary vesicoureteral reflux [abstract no: COD. PP 81]. Pediatric Nephrology2006;21(10):1542. [CENTRAL: CN‐00724966] LeeSJ , ShimYH , ChoSJ , LeeJW . Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatric Nephrology2007;22(9):1315‐20. [MEDLINE: 17530295] ">Lee 2007a</a>). </p> </section> <section id="CD008772-sec-0060"> <h5 class="title">Interventions</h5> <p>The species and mode of administration of the probiotic intervention varied widely among studies, as did duration of therapy (eight weeks to 12 months). Details of formulations and species of probiotics in the studies are presented in <a href="./references#CD008772-sec-0092" title="">Characteristics of included studies</a>. </p> </section> <section id="CD008772-sec-0061"> <h5 class="title">Outcomes</h5> <p>Only <a href="./references#CD008772-bbs2-0008" title="ReidG , CharbonneauD , ErbJ , KochanowskiB , BeuermanD , PoehnerR , et al. Oral use of Lactobacillus rhamnosus GR‐1 and L. fermentum RC‐14 significantly alters vaginal flora: randomized, placebo‐controlled trial in 64 healthy women. FEMS Immunology &amp; Medical Microbiology2003;35(2):131‐4. [MEDLINE: 12628548] ">Reid 2003</a> did not report our primary outcome of UTI, although definitions varied by study (<a href="./references#CD008772-sec-0092" title="">Characteristics of included studies</a>). Few studies reported on our prespecified secondary outcomes. Four studies reported on adverse events (<a href="./references#CD008772-bbs2-0002" title="CzajaCA , StapletonAE , Yarova‐YarovayaY , StammWE . Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infectious Diseases in Obstetrics &amp; Gynecology2007;2007:35387. [MEDLINE: 18288237] ">Czaja 2007</a>; <a href="./references#CD008772-bbs2-0007" title="ReidG , BruceAW , TaylorM . Influence of three‐day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clinical Therapeutics1992;14(1):11‐6. [MEDLINE: 1576619] ">Reid 1992</a>; <a href="./references#CD008772-bbs2-0008" title="ReidG , CharbonneauD , ErbJ , KochanowskiB , BeuermanD , PoehnerR , et al. Oral use of Lactobacillus rhamnosus GR‐1 and L. fermentum RC‐14 significantly alters vaginal flora: randomized, placebo‐controlled trial in 64 healthy women. FEMS Immunology &amp; Medical Microbiology2003;35(2):131‐4. [MEDLINE: 12628548] ">Reid 2003</a>; <a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a>), and only two considered serious adverse events (<a href="./references#CD008772-bbs2-0002" title="CzajaCA , StapletonAE , Yarova‐YarovayaY , StammWE . Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infectious Diseases in Obstetrics &amp; Gynecology2007;2007:35387. [MEDLINE: 18288237] ">Czaja 2007</a>; <a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a>). </p> </section> </section> <section id="CD008772-sec-0062"> <h4 class="title">Excluded studies</h4> <p>Seven studies were excluded (<a href="./references#CD008772-sec-0093" title="">Characteristics of excluded studies</a>). <a href="./references#CD008772-bbs2-0011" title="DaniC , BiadaioliR , BertiniG , MartelliE , RubaltelliFF . Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double‐blind study. Biology of the Neonate2002;82(2):103‐8. [MEDLINE: 12169832] ">Dani 2002</a> was conducted in a neonatal population; <a href="./references#CD008772-bbs2-0010" title="ColodnerR , EdelsteinH , ChazanB , RazR . Vaginal colonization by orally administered Lactobacillus rhamnosus GG. Israel Medical Association Journal: Imaj2003;5(11):767‐9. [MEDLINE: 14650098] ">Colodner 2003</a> did not include an arm where participants did not receive a probiotic; <a href="./references#CD008772-bbs2-0014" title="MolanderU , MilsomI , EkelundP , MellstromD , ErikssonO . Effect of oral oestriol on vaginal flora and cytology and urogenital symptoms in the post‐menopause. Maturitas1990;12(2):113‐20. [MEDLINE: 2255263] ">Molander 1990</a> did not include investigation of a probiotic; and <a href="./references#CD008772-bbs2-0015" title="NCT00900653 . Low dose estriol with lactobacilli (Gynoflor) treatment for preventing recurrent urinary tract infection in postmenopausal women: a randomized, open, parallel‐group study. www.clinicaltrials.gov/ct2/show/NCT00900653 (accessed 21 September 2015). ">NCT00900653</a> studied a combination of probiotic and hormonal therapies. <a href="./references#CD008772-bbs2-0012" title="ManleyK , FraenkelM , MayallB , PowerD . Yoghurt and VRE: Can a probiotic make a difference? [abstract no: 007]. Journal of Renal Nutrition2008;18(3 Suppl 1):S3. ManleyKJ , FraenkelMB , MayallBC , PowerDA . Probiotic treatment of vancomycin‐resistant enterococci: a randomised controlled trial. Medical Journal of Australia2007;186(9):454‐7. [MEDLINE: 17484706] ">Manley 2007</a> and <a href="./references#CD008772-bbs2-0016" title="PushkarevAM . Efficacy of probiotic bactisporin in therapy of intrahospital urinary infection. Urologiia (Moscow, Russia)2005, (4):48‐53. [MEDLINE: 16158748] ">Pushkarev 2005</a> studied treatment rather than prophylaxis; <a href="./references#CD008772-bbs2-0017" title="RanganathanN , FriedmanEA , TamP , RaoV , RanganathanP , DheerR . Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6‐month pilot scale trial in Canada. Current Medical Research &amp; Opinion2009;25(8):1919‐30. [MEDLINE: 19558344] RanganathanN , RanganathanP , FriedmanEA , JosephA , DelanoB , GoldfarbDS , et al. Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Advances in Therapy2010;27(9):634‐47. [MEDLINE: 20721651] ">Ranganathan 2009</a> enrolled people with chronic kidney disease (CKD) to determine if probiotics exerted renoprotective effects and reduced uraemia symptoms. </p> </section> </section> <section id="CD008772-sec-0063"> <h3 class="title">Risk of bias in included studies</h3> <p><a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a> was large and methods and events were adequately reported; however, most studies had small sample sizes and reported insufficient methodological detail to enable robust assessment (<a href="#CD008772-fig-0002">Figure 2</a>; <a href="#CD008772-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD008772-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD008772-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD008772-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD008772-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <p>Overall, there was a high risk of bias among the included studies. This meant that we were unable to draw firm conclusions or determine if any reported treatment effects may be misleading or represent overestimates. </p> <section id="CD008772-sec-0064"> <h4 class="title">Allocation</h4> <p>Three studies (<a href="./references#CD008772-bbs2-0003" title="FerraraP , RomanielloL , VitelliO , GattoA , ServaM , CataldiL . Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scandinavian Journal of Urology &amp; Nephrology2009;43(5):369‐72. [MEDLINE: 19921981] ">Ferrara 2009</a>; <a href="./references#CD008772-bbs2-0004" title="KontiokariT , SundqvistK , NuutinenM , PokkaT , KoskelaM , UhariM . Randomised trial of cranberry‐lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ2001;322(7302):1‐5. [MEDLINE: 11431298] ">Kontiokari 2001</a>; <a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a>) reported on adequate methods of sequence generation and the other six studies (<a href="./references#CD008772-bbs2-0001" title="BaerheimA , LarsenE , DigranesA . Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scandinavian Journal of Primary Health Care1994;12(4):239‐43. [MEDLINE: 7863140] ">Baerheim 1994</a>; <a href="./references#CD008772-bbs2-0002" title="CzajaCA , StapletonAE , Yarova‐YarovayaY , StammWE . Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infectious Diseases in Obstetrics &amp; Gynecology2007;2007:35387. [MEDLINE: 18288237] ">Czaja 2007</a>; <a href="./references#CD008772-bbs2-0005" title="LeeSJ , KimHJ , ShimYH , LeeJW . The effect of probiotic prophylaxis for preventing recurrent urinary tract infection in children with persistent primary vesicoureteral reflux [abstract no: COD. PP 81]. Pediatric Nephrology2006;21(10):1542. [CENTRAL: CN‐00724966] LeeSJ , ShimYH , ChoSJ , LeeJW . Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatric Nephrology2007;22(9):1315‐20. [MEDLINE: 17530295] ">Lee 2007a</a>; <a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a>; <a href="./references#CD008772-bbs2-0007" title="ReidG , BruceAW , TaylorM . Influence of three‐day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clinical Therapeutics1992;14(1):11‐6. [MEDLINE: 1576619] ">Reid 1992</a>; <a href="./references#CD008772-bbs2-0008" title="ReidG , CharbonneauD , ErbJ , KochanowskiB , BeuermanD , PoehnerR , et al. Oral use of Lactobacillus rhamnosus GR‐1 and L. fermentum RC‐14 significantly alters vaginal flora: randomized, placebo‐controlled trial in 64 healthy women. FEMS Immunology &amp; Medical Microbiology2003;35(2):131‐4. [MEDLINE: 12628548] ">Reid 2003</a>) did not describe sequence generation methods. </p> <p>Four studies reported adequate allocation concealment (<a href="./references#CD008772-bbs2-0002" title="CzajaCA , StapletonAE , Yarova‐YarovayaY , StammWE . Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infectious Diseases in Obstetrics &amp; Gynecology2007;2007:35387. [MEDLINE: 18288237] ">Czaja 2007</a>; <a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a>; <a href="./references#CD008772-bbs2-0007" title="ReidG , BruceAW , TaylorM . Influence of three‐day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clinical Therapeutics1992;14(1):11‐6. [MEDLINE: 1576619] ">Reid 1992</a>; <a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a>). Allocation concealment was unclear for the remaining five studies. </p> </section> <section id="CD008772-sec-0065"> <h4 class="title">Blinding</h4> <p>Two included studies were adequately described as double blind (<a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a>; <a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a>), two were open label (<a href="./references#CD008772-bbs2-0003" title="FerraraP , RomanielloL , VitelliO , GattoA , ServaM , CataldiL . Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scandinavian Journal of Urology &amp; Nephrology2009;43(5):369‐72. [MEDLINE: 19921981] ">Ferrara 2009</a>; <a href="./references#CD008772-bbs2-0004" title="KontiokariT , SundqvistK , NuutinenM , PokkaT , KoskelaM , UhariM . Randomised trial of cranberry‐lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ2001;322(7302):1‐5. [MEDLINE: 11431298] ">Kontiokari 2001</a>) and there were insufficient data to assess blinding for the remaining studies; blinding was either not reported or lacked sufficient detail to determine who was blinded. </p> </section> <section id="CD008772-sec-0066"> <h4 class="title">Incomplete outcome data</h4> <p>Satisfactory explanation was provided for changes in the number of participants for only one of the studies assessed (<a href="./references#CD008772-bbs2-0002" title="CzajaCA , StapletonAE , Yarova‐YarovayaY , StammWE . Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infectious Diseases in Obstetrics &amp; Gynecology2007;2007:35387. [MEDLINE: 18288237] ">Czaja 2007</a>). <a href="./references#CD008772-bbs2-0008" title="ReidG , CharbonneauD , ErbJ , KochanowskiB , BeuermanD , PoehnerR , et al. Oral use of Lactobacillus rhamnosus GR‐1 and L. fermentum RC‐14 significantly alters vaginal flora: randomized, placebo‐controlled trial in 64 healthy women. FEMS Immunology &amp; Medical Microbiology2003;35(2):131‐4. [MEDLINE: 12628548] ">Reid 2003</a> had a significant proportion of their small study population excluded from analysis; attrition was significant and not explained satisfactorily in three studies (<a href="./references#CD008772-bbs2-0004" title="KontiokariT , SundqvistK , NuutinenM , PokkaT , KoskelaM , UhariM . Randomised trial of cranberry‐lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ2001;322(7302):1‐5. [MEDLINE: 11431298] ">Kontiokari 2001</a>; <a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a>, <a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a>). Remaining studies lacked sufficient information to determine if attrition was likely to result in significant bias. Due to this incomplete follow‐up, worst case scenarios were undertaken for both the probiotics in comparison to placebo analysis and the probiotics in comparison to antibiotics analysis. </p> </section> <section id="CD008772-sec-0067"> <h4 class="title">Selective reporting</h4> <p>Many of the included studies either did not report secondary outcomes, or lacked sufficient detail in reporting secondary outcomes; many of our prespecified secondary outcomes were not addressed, including all‐cause mortality and number with at least one confirmed case of bacteraemia or fungaemia. </p> <p>We searched for published protocols for the included studies. Protocols were found for <a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a> and <a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a>. The outcomes reported in <a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a> aligned completely with the published protocol. The published report of the <a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a> included several outcomes that were not prespecified in the protocol: mean number of antibiotic prescriptions for UTI treatment; and a subgroup analysis of mean number of clinical recurrences in women with complicated versus uncomplicated UTI. </p> </section> <section id="CD008772-sec-0068"> <h4 class="title">Other potential sources of bias</h4> <p>Several studies were funded by manufacturing companies (<a href="./references#CD008772-bbs2-0002" title="CzajaCA , StapletonAE , Yarova‐YarovayaY , StammWE . Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infectious Diseases in Obstetrics &amp; Gynecology2007;2007:35387. [MEDLINE: 18288237] ">Czaja 2007</a>; <a href="./references#CD008772-bbs2-0007" title="ReidG , BruceAW , TaylorM . Influence of three‐day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clinical Therapeutics1992;14(1):11‐6. [MEDLINE: 1576619] ">Reid 1992</a>), and one had an issue with supply that resulted in treatment duration inequality between the study arms (<a href="./references#CD008772-bbs2-0004" title="KontiokariT , SundqvistK , NuutinenM , PokkaT , KoskelaM , UhariM . Randomised trial of cranberry‐lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ2001;322(7302):1‐5. [MEDLINE: 11431298] ">Kontiokari 2001</a>). UTI definitions were fairly consistent among studies, although microbiological criteria ranged from at least 10<sup>3</sup> CFU/mL to 10<sup>5</sup> CFU/mL and clinical criteria were more stringent in some studies compared with others. </p> </section> </section> <section id="CD008772-sec-0069"> <h3 class="title" id="CD008772-sec-0069">Effects of interventions</h3> <p>See: <a href="./full#CD008772-tbl-0001"><b>Summary of findings for the main comparison</b> </a> </p> <section id="CD008772-sec-0070"> <h4 class="title">Primary outcome</h4> <p>The primary outcome was to assess numbers of participants with at least one symptomatic bacterial UTI in each group (as confirmed by a catheter specimen of urine, midstream urine specimen if possible, or a clean catch specimen, and defined as &gt; 10<sup>5</sup> CFU/mL or as defined by triallists). </p> <p>Analyses were conducted according to probiotics in women and probiotics in children with VUR. Placebo‐controlled studies were subdivided into studies that enrolled women and children who had recently been treated with antibiotics for UTI (<a href="./references#CD008772-bbs2-0003" title="FerraraP , RomanielloL , VitelliO , GattoA , ServaM , CataldiL . Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scandinavian Journal of Urology &amp; Nephrology2009;43(5):369‐72. [MEDLINE: 19921981] ">Ferrara 2009</a>; <a href="./references#CD008772-bbs2-0004" title="KontiokariT , SundqvistK , NuutinenM , PokkaT , KoskelaM , UhariM . Randomised trial of cranberry‐lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ2001;322(7302):1‐5. [MEDLINE: 11431298] ">Kontiokari 2001</a>; <a href="./references#CD008772-bbs2-0007" title="ReidG , BruceAW , TaylorM . Influence of three‐day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clinical Therapeutics1992;14(1):11‐6. [MEDLINE: 1576619] ">Reid 1992</a>; <a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a>) and studies enrolling participants who had previous UTIs (<a href="./references#CD008772-bbs2-0001" title="BaerheimA , LarsenE , DigranesA . Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scandinavian Journal of Primary Health Care1994;12(4):239‐43. [MEDLINE: 7863140] ">Baerheim 1994</a>; <a href="./references#CD008772-bbs2-0002" title="CzajaCA , StapletonAE , Yarova‐YarovayaY , StammWE . Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infectious Diseases in Obstetrics &amp; Gynecology2007;2007:35387. [MEDLINE: 18288237] ">Czaja 2007</a>). We decided to first determine if probiotics exerted a positive effect versus placebo before analysing studies versus active comparators. </p> <p>A meta‐analysis of six studies that involved 352 randomised women and children demonstrated no significant reduction in the risk of recurrent symptomatic bacterial UTI between probiotics and placebo (<a href="./references#CD008772-fig-0004" title="">Analysis 1.1</a> (6 studies, 352 participants): RR 0.82, 95% CI 0.60 to 1.12; I<sup>2</sup> = 23%), heterogeneity was low. The confidence interval for all studies suggests a range that includes a 15.8 % absolute decrease to a 4.7% absolute increase in the risk of recurrent bacterial UTI with probiotics versus placebo given that the placebo rate of recurrence was 39.5% over 8 to 52 weeks. </p> <p><a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a> reported no significant difference in the rate of recurrent symptomatic bacterial UTI in women between probiotics and antibiotics (<a href="./references#CD008772-fig-0006" title="">Analysis 2.1</a> (1 study, 223 women): RR 1.12, 95% CI 0.95 to 1.33). </p> <p><a href="./references#CD008772-bbs2-0005" title="LeeSJ , KimHJ , ShimYH , LeeJW . The effect of probiotic prophylaxis for preventing recurrent urinary tract infection in children with persistent primary vesicoureteral reflux [abstract no: COD. PP 81]. Pediatric Nephrology2006;21(10):1542. [CENTRAL: CN‐00724966] LeeSJ , ShimYH , ChoSJ , LeeJW . Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatric Nephrology2007;22(9):1315‐20. [MEDLINE: 17530295] ">Lee 2007a</a> included children with VUR. There was no significant difference in the rate of recurrent symptomatic bacterial UTI between probiotics and antibiotics (<a href="./references#CD008772-fig-0009" title="">Analysis 3.1</a> (1 study, 96 children): RR 0.54, 95% CI 0.24 to 1.23). </p> <p>We analysed six month recurrent UTI data from <a href="./references#CD008772-bbs2-0004" title="KontiokariT , SundqvistK , NuutinenM , PokkaT , KoskelaM , UhariM . Randomised trial of cranberry‐lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ2001;322(7302):1‐5. [MEDLINE: 11431298] ">Kontiokari 2001</a>. However, the authors also reported recurrent UTI at 12 months; a sensitivity analysis demonstrated that the results of the meta‐analysis did not change meaningfully if 12 month data were used. Three studies did not report on this outcome and this may have improved the precision of the effect size if the data were available. <a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a> reported 17 and 13 recurrent symptomatic bacterial UTIs for probiotics and placebo respectively. However, correspondence with the lead author indicated that two women in each arm of the study had symptomatic UTI but these were not confirmed with positive cultures; therefore, these events were excluded. We included these unconfirmed UTI in our analysis. In a sensitivity analysis, the results of the meta‐analysis did not change meaningfully if only culture‐confirmed UTI data were used. </p> </section> <section id="CD008772-sec-0071"> <h4 class="title">Secondary outcomes</h4> <p>None of the included studies reported numbers of participants with at least one asymptomatic bacterial UTI, all‐cause mortality or those with at least one confirmed case of bacteraemia or fungaemia. The only secondary outcomes of interest reported by the included studies were withdrawal due to adverse events, total adverse events and numbers of participants with at least one non‐fatal serious adverse event. </p> <p>Withdrawal due to adverse events was reported by <a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a> and <a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a>. <a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a> reported that withdrawals due to adverse events occurred in six probiotic participants (5.2%) versus 15 antibiotic participants (12.2%). <a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a> noted that one placebo group participant discontinued treatment due to an adverse event. </p> <p><a href="./references#CD008772-bbs2-0003" title="FerraraP , RomanielloL , VitelliO , GattoA , ServaM , CataldiL . Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scandinavian Journal of Urology &amp; Nephrology2009;43(5):369‐72. [MEDLINE: 19921981] ">Ferrara 2009</a>, <a href="./references#CD008772-bbs2-0004" title="KontiokariT , SundqvistK , NuutinenM , PokkaT , KoskelaM , UhariM . Randomised trial of cranberry‐lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ2001;322(7302):1‐5. [MEDLINE: 11431298] ">Kontiokari 2001</a>, and <a href="./references#CD008772-bbs2-0007" title="ReidG , BruceAW , TaylorM . Influence of three‐day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clinical Therapeutics1992;14(1):11‐6. [MEDLINE: 1576619] ">Reid 1992</a> did not report adverse events. <a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a> and <a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a> reported participants who experienced at least one adverse event but data were not meta‐analysed because participants in the <a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a> control group received an antibiotic, and <a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a> provided a placebo to control group participants. <a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a> reported that 66 probiotic (57.4%) and 72 antibiotic participants (58.5%) respectively experienced at least one adverse event (the most commonly reported adverse effects in both groups were diarrhoea, nausea, vomiting, constipation and vaginal symptoms). <a href="./references#CD008772-bbs2-0008" title="ReidG , CharbonneauD , ErbJ , KochanowskiB , BeuermanD , PoehnerR , et al. Oral use of Lactobacillus rhamnosus GR‐1 and L. fermentum RC‐14 significantly alters vaginal flora: randomized, placebo‐controlled trial in 64 healthy women. FEMS Immunology &amp; Medical Microbiology2003;35(2):131‐4. [MEDLINE: 12628548] ">Reid 2003</a> identified adverse events through a questionnaire that was sent to patients. They reported that no probiotic patients reported an adverse event however it is unclear how many comparator group patients experienced at least one adverse event; they only reported that 2 comparator patients reported yeast infections. </p> <p><a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a> reported that 28 probiotic (56%) and 25 placebo participants (50%) experienced at least one adverse event (the most common were vaginal discharge, itching and moderate abdominal discomfort). </p> <p><a href="./references#CD008772-bbs2-0001" title="BaerheimA , LarsenE , DigranesA . Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scandinavian Journal of Primary Health Care1994;12(4):239‐43. [MEDLINE: 7863140] ">Baerheim 1994</a> stated that treatment was well tolerated in both groups; four participants from the probiotic arm and one from placebo complained of discharge, with no other adverse effects noted. </p> <p><a href="./references#CD008772-bbs2-0002" title="CzajaCA , StapletonAE , Yarova‐YarovayaY , StammWE . Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infectious Diseases in Obstetrics &amp; Gynecology2007;2007:35387. [MEDLINE: 18288237] ">Czaja 2007</a> documented a range of self‐reported adverse effects including abnormal vaginal discharge, external genital irritation, vaginal candidiasis, vaginal odour, abdominal pain and dysuria. Abnormal vaginal discharge occurred in about half of all participants, but the overall frequency of adverse effects was low. </p> <p><a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a> and <a href="./references#CD008772-bbs2-0002" title="CzajaCA , StapletonAE , Yarova‐YarovayaY , StammWE . Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infectious Diseases in Obstetrics &amp; Gynecology2007;2007:35387. [MEDLINE: 18288237] ">Czaja 2007</a> reported serious adverse events. In <a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a>, no significant difference in serious adverse events was noted; 17 probiotic (14.8%) and 14 antibiotic participants (11.4%) experienced at least one serious adverse event. </p> </section> <section id="CD008772-sec-0072"> <h4 class="title">Subgroup analyses</h4> <p>In a post‐hoc subgroup analysis, there was no significant difference in recurrence of UTI between the subgroups of women without a UTI prior to enrolment compared (<a href="./references#CD008772-fig-0004" title="">Analysis 1.1</a>.1 (2 studies, 77 participants): RR 1.12, 95% CI 0.65 to 1.93; I<sup>2</sup> = 0%) with those with UTI being treated with antimicrobials at enrolment (<a href="./references#CD008772-fig-0004" title="">Analysis 1.1</a>.2 (4 studies, 275 participants): RR 0.74, 95% CI 0.52 to 1.05; I<sup>2</sup> = 16%). The overall pooled estimate for all studies in both subgroups was not significantly different from the pooled estimate of each subgroup (Test for subgroup differences: Chi<sup>2</sup> = 1.57, df = 1 (P = 0.21), I<sup>2</sup> = 36.5%). </p> </section> <section id="CD008772-sec-0073"> <h4 class="title">Sensitivity analyses</h4> <p>Sensitivity analyses were planned to determine if treatment effects on recurrent symptomatic bacterial UTI rates differed in studies based on a number of variables. Removal of studies that were open label or that had unclear allocation concealment did not change the effect of probiotics on recurrent symptomatic bacterial UTI however only few studies had unclear allocation concealment (<a href="./references#CD008772-bbs2-0001" title="BaerheimA , LarsenE , DigranesA . Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scandinavian Journal of Primary Health Care1994;12(4):239‐43. [MEDLINE: 7863140] ">Baerheim 1994</a>; <a href="./references#CD008772-bbs2-0003" title="FerraraP , RomanielloL , VitelliO , GattoA , ServaM , CataldiL . Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scandinavian Journal of Urology &amp; Nephrology2009;43(5):369‐72. [MEDLINE: 19921981] ">Ferrara 2009</a>; <a href="./references#CD008772-bbs2-0004" title="KontiokariT , SundqvistK , NuutinenM , PokkaT , KoskelaM , UhariM . Randomised trial of cranberry‐lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ2001;322(7302):1‐5. [MEDLINE: 11431298] ">Kontiokari 2001</a>) or were open label (<a href="./references#CD008772-bbs2-0003" title="FerraraP , RomanielloL , VitelliO , GattoA , ServaM , CataldiL . Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scandinavian Journal of Urology &amp; Nephrology2009;43(5):369‐72. [MEDLINE: 19921981] ">Ferrara 2009</a>; <a href="./references#CD008772-bbs2-0004" title="KontiokariT , SundqvistK , NuutinenM , PokkaT , KoskelaM , UhariM . Randomised trial of cranberry‐lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ2001;322(7302):1‐5. [MEDLINE: 11431298] ">Kontiokari 2001</a>) and it was felt that sensitivity analyses would not be informative and maybe misleading. </p> <p>Sensitivity analysis was also conducted for symptomatic bacterial UTI involving <a href="./references#CD008772-bbs2-0002" title="CzajaCA , StapletonAE , Yarova‐YarovayaY , StammWE . Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infectious Diseases in Obstetrics &amp; Gynecology2007;2007:35387. [MEDLINE: 18288237] ">Czaja 2007</a>, <a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a> and <a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a> as these three studies suggested that not all randomised patients were included in the UTI analysis; hence we wanted to see the impact of imputing data for a worst case scenario. In this analysis all missing patients in one group were assumed to have had UTI, and those missing from the other group were assumed to not have had UTI. For the comparison of probiotics versus placebo, the effect did not change using a worst case scenario for probiotics (<a href="./references#CD008772-fig-0005" title="">Analysis 1.2</a>: RR 0.94, 95% CI 0.63 to 1.39; I<sup>2</sup> = 49%). For the comparison of probiotics versus antibiotics, a worst case scenario for antibiotics of the <a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a> now demonstrated that fewer probiotic patients experienced a recurrent symptomatic bacterial UTI versus antibiotics (25 antibiotic patients, <a href="./references#CD008772-fig-0008" title="">Analysis 2.3</a>; RR 0.83, 95% CI 0.74 to 0.94). When the worst case scenario analysis for probiotics was conducted, more probiotic patients had recurrent symptomatic bacterial UTI (5 probiotic patients, <a href="./references#CD008772-fig-0007" title="">Analysis 2.2</a>; RR 1.19, 95% CI 1.01 to 1.40). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD008772-sec-0074" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008772-sec-0074">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008772-sec-0110">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD008772-sec-0074"></div> <section id="CD008772-sec-0075"> <h3 class="title" id="CD008772-sec-0075">Summary of main results</h3> <p>This review included nine studies involving a total of 735 participants. No significant difference in risk of recurrent UTI was seen for probiotics in comparison to placebo or antibiotic prophylaxis in either women or children. There was no significant difference found between probiotics and either placebo or antibiotic prophylaxis for harms. </p> <p>The studies included in this review were generally small and of poor quality with inconsistent and limited reporting of harm, and as such the data are insufficient to exclude either a benefit or harm from probiotics versus either placebo or antibiotic prophylaxis. </p> <p>Only <a href="./references#CD008772-bbs2-0006" title="BeerepootMA , StobberinghEE , GeerlingsSE . A study of non‐antibiotic versus antibiotic prophylaxis for recurrent urinary‐tract infections in women (the NAPRUTI study) [Onderzoek naar niet‐antibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI‐studie)]. Nederlands Tijdschrift voor Geneeskunde2006;150(10):574‐5. [MEDLINE: 16566424] BeerepootMA , Ter RietG , NysS , van derWalWM , DeBorgieCAJM , deReijkeTM , et al. Lactobacilli versus antibiotics to prevent urinary tract infections: A randomized, double‐blind, noninferiority trial in postmenopausal women [Lactobacillen versus antibiotica ter preventie van urineweginfecties: 'Non‐in feriority'‐studie bij post men opauzale vrouwen]. Nederlands Tijdschrift voor Geneeskunde2013;157(10):A5674. [EMBASE: 2013248979] BeerepootMA , Ter RietG , NysS , van derWalWM , deBorgieCA , deReijkeTM , et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double‐blind, noninferiority trial in postmenopausal women. Archives of Internal Medicine2012;172(9):704‐12. [MEDLINE: 22782199] BeerepootMA , denHeijerCD , PendersJ , PrinsJM , StobberinghEE , GeerlingsSE . Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis. Clinical Microbiology &amp; Infection2012;18(4):E84‐90. [MEDLINE: 22329638] BeerepootMA , van derWalWM , NysS . Lactobacillus rhamnosus gr‐1 and l. Reuteri rc‐14 versus trimethoprim‐sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (RUTIs) in postmenopausal women: a randomized double‐blind non‐inferiority trial [abstract no: L1‐1656a]. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2012 Sep 12‐15; San Francisco (CA). 2012. ">NAPRUTI Study II 2006</a> compared probiotics and antibiotics; no significant difference in the rate of recurrent symptomatic bacterial UTI or harm was found between groups. </p> <p>Adverse events, when reported, were poorly described with insufficient data to perform statistical evaluation. Overall the frequency of reported side effects was low and mild in nature (e.g. vaginal discomfort). </p> <p>We suggest caution when interpreting the lack of a subgroup difference in <a href="./references#CD008772-fig-0004" title="">Analysis 1.1</a>, as there were too few studies to be able to confidently conclude the presence or absence of subgroup differences. </p> <p>There was insufficient evidence to comment on the differences in effects of probiotics in children and women as only one study included only children (<a href="./references#CD008772-bbs2-0003" title="FerraraP , RomanielloL , VitelliO , GattoA , ServaM , CataldiL . Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scandinavian Journal of Urology &amp; Nephrology2009;43(5):369‐72. [MEDLINE: 19921981] ">Ferrara 2009</a>) and a subgroup analysis may be misleading. </p> </section> <section id="CD008772-sec-0076"> <h3 class="title" id="CD008772-sec-0076">Overall completeness and applicability of evidence</h3> <p>We included nine studies in this review ranging from 30 to 252 participants totalling a relatively small overall sample of 735 participants. No statistically significant difference was seen in recurrent symptomatic bacterial UTI. Given the low overall quality and quantity of data available a decrease or increase in recurrent symptomatic UTI cannot be ruled out. </p> <p>There was some reporting bias in that several studies did not report on symptomatic bacterial UTI, and very limited information on harm. For example, <a href="./references#CD008772-bbs2-0008" title="ReidG , CharbonneauD , ErbJ , KochanowskiB , BeuermanD , PoehnerR , et al. Oral use of Lactobacillus rhamnosus GR‐1 and L. fermentum RC‐14 significantly alters vaginal flora: randomized, placebo‐controlled trial in 64 healthy women. FEMS Immunology &amp; Medical Microbiology2003;35(2):131‐4. [MEDLINE: 12628548] ">Reid 2003</a> did not report symptomatic bacterial UTI recurrence; these data would have been valuable because the meta‐analysis of studies that did report this outcome did not rule out a clinically important increased or decreased risk. These studies also included different patient populations resulting in the analysis of separate small groups of studies instead of the evidence base as a whole. </p> <p>There was insufficient evidence to determine if probiotics provide a therapeutic advantage over placebo for susceptible patient populations (e.g. previous history of UTI, women, school‐aged girls, men with enlarged prostates, and the elderly). Included studies randomised primarily women and young girls with no studies enrolling men with enlarged prostates or the elderly. </p> </section> <section id="CD008772-sec-0077"> <h3 class="title" id="CD008772-sec-0077">Quality of the evidence</h3> <p>Our assessments suggested an unclear or high risk of bias (<a href="#CD008772-fig-0002">Figure 2</a>; <a href="#CD008772-fig-0003">Figure 3</a>, <a href="./full#CD008772-tbl-0001">summary of findings Table for the main comparison</a>). As such, evidence has been downgraded to low for all outcomes listed in the <a href="./full#CD008772-tbl-0001">summary of findings Table for the main comparison</a>. This suggested that treatment effects were likely overestimated and that better methodological control is required in future research. Future studies should model methods from <a href="./references#CD008772-bbs2-0009" title="StapletonAE , Au‐YeungM , HootonTM , FredricksDN , RobertsPL , CzajaCA , et al. Randomized, placebo‐controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clinical Infectious Diseases2011;52(10):1212‐7. [MEDLINE: 21498386] ">Stapleton 2011</a>. Adequate allocation concealment was described in four of the eight included studies; only two studies were double blinded. Attrition bias was of concern in all but one included study.  </p> <p>The available evidence varied in terms of probiotic used, route of delivery and duration of therapy. These differences make drawing specific conclusions difficult and likely contribute to the heterogeneity seen in the pooled estimates. Most included studies did not systematically collect adverse event information, thus we could not draw conclusions regarding the potential harms associated with these therapies. </p> </section> <section id="CD008772-sec-0078"> <h3 class="title" id="CD008772-sec-0078">Potential biases in the review process</h3> <p>Our literature search included several international databases and search criteria were intentionally broad to identify as many potentially relevant articles as possible. We did not exclude studies published in languages other than English. We contacted study authors for missing information. </p> </section> <section id="CD008772-sec-0079"> <h3 class="title" id="CD008772-sec-0079">Agreements and disagreements with other studies or reviews</h3> <p><a href="./references#CD008772-bbs2-0028" title="GrinPM , KowalewskaPM , AlahazanniW , Fox‐RobichaudAE . Lactobacillus for preventing recurrent urinary tract infections in women: meta‐analysis. Canadian Journal of Urology2013;20(1):6607‐14. [MEDLINE: 23433130] ">Grin 2013</a> is the most recent systematic review on this topic. <a href="./references#CD008772-bbs2-0028" title="GrinPM , KowalewskaPM , AlahazanniW , Fox‐RobichaudAE . Lactobacillus for preventing recurrent urinary tract infections in women: meta‐analysis. Canadian Journal of Urology2013;20(1):6607‐14. [MEDLINE: 23433130] ">Grin 2013</a> included five RCTs, against nine included in this review. Our assessment is that <a href="./references#CD008772-bbs2-0028" title="GrinPM , KowalewskaPM , AlahazanniW , Fox‐RobichaudAE . Lactobacillus for preventing recurrent urinary tract infections in women: meta‐analysis. Canadian Journal of Urology2013;20(1):6607‐14. [MEDLINE: 23433130] ">Grin 2013</a> limited their search to include only studies that included premenopausal women with history of UTI. Our inclusion criteria did not limit to a particular population nor did it exclude studies in healthy people (e.g. <a href="./references#CD008772-bbs2-0008" title="ReidG , CharbonneauD , ErbJ , KochanowskiB , BeuermanD , PoehnerR , et al. Oral use of Lactobacillus rhamnosus GR‐1 and L. fermentum RC‐14 significantly alters vaginal flora: randomized, placebo‐controlled trial in 64 healthy women. FEMS Immunology &amp; Medical Microbiology2003;35(2):131‐4. [MEDLINE: 12628548] ">Reid 2003</a> enrolled healthy women and met our inclusion criteria). <a href="./references#CD008772-bbs2-0028" title="GrinPM , KowalewskaPM , AlahazanniW , Fox‐RobichaudAE . Lactobacillus for preventing recurrent urinary tract infections in women: meta‐analysis. Canadian Journal of Urology2013;20(1):6607‐14. [MEDLINE: 23433130] ">Grin 2013</a> concluded that it was possible that certain strains lactobacillus‐containing suppositories could prevent recurrent UTI in premenopausal women. <a href="./references#CD008772-bbs2-0028" title="GrinPM , KowalewskaPM , AlahazanniW , Fox‐RobichaudAE . Lactobacillus for preventing recurrent urinary tract infections in women: meta‐analysis. Canadian Journal of Urology2013;20(1):6607‐14. [MEDLINE: 23433130] ">Grin 2013</a> suggested that more RCTs were required to be certain of the effect on recurrent UTI. In addition, <a href="./references#CD008772-bbs2-0028" title="GrinPM , KowalewskaPM , AlahazanniW , Fox‐RobichaudAE . Lactobacillus for preventing recurrent urinary tract infections in women: meta‐analysis. Canadian Journal of Urology2013;20(1):6607‐14. [MEDLINE: 23433130] ">Grin 2013</a> suggested that current RCTs did not enable definitive conclusions to be made about the safety of probiotics. </p> <p>In general, our conclusions are similar to <a href="./references#CD008772-bbs2-0028" title="GrinPM , KowalewskaPM , AlahazanniW , Fox‐RobichaudAE . Lactobacillus for preventing recurrent urinary tract infections in women: meta‐analysis. Canadian Journal of Urology2013;20(1):6607‐14. [MEDLINE: 23433130] ">Grin 2013</a> in that more RCTs are required to determine the net health impact of probiotics, although our conclusions apply to a broader patient population. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD008772-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/urn:x-wiley:14651858:media:CD008772:CD008772-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_t/tCD008772-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD008772-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/full#CD008772-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008772-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/urn:x-wiley:14651858:media:CD008772:CD008772-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_t/tCD008772-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD008772-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/full#CD008772-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008772-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/urn:x-wiley:14651858:media:CD008772:CD008772-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_t/tCD008772-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD008772-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/full#CD008772-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008772-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/urn:x-wiley:14651858:media:CD008772:CD008772-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_t/tCD008772-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics versus placebo in adults and children, Outcome 1 Symptomatic bacterial UTI." data-id="CD008772-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Probiotics versus placebo in adults and children, Outcome 1 Symptomatic bacterial UTI. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/references#CD008772-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008772-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/urn:x-wiley:14651858:media:CD008772:CD008772-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_t/tCD008772-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics versus placebo in adults and children, Outcome 2 Worst case scenario ‐ symptomatic bacterial UTI." data-id="CD008772-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Probiotics versus placebo in adults and children, Outcome 2 Worst case scenario ‐ symptomatic bacterial UTI. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/references#CD008772-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008772-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/urn:x-wiley:14651858:media:CD008772:CD008772-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_t/tCD008772-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Probiotics versus antibiotics in women, Outcome 1 Symptomatic bacterial UTI." data-id="CD008772-fig-0006" src="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Probiotics versus antibiotics in women, Outcome 1 Symptomatic bacterial UTI. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/references#CD008772-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008772-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/urn:x-wiley:14651858:media:CD008772:CD008772-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_t/tCD008772-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Probiotics versus antibiotics in women, Outcome 2 Worst case scenario probiotics ‐ symptomatic bacterial UTI." data-id="CD008772-fig-0007" src="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Probiotics versus antibiotics in women, Outcome 2 Worst case scenario probiotics ‐ symptomatic bacterial UTI. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/references#CD008772-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008772-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/urn:x-wiley:14651858:media:CD008772:CD008772-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_t/tCD008772-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Probiotics versus antibiotics in women, Outcome 3 Worst case scenario antibiotics ‐ symptomatic bacterial UTI." data-id="CD008772-fig-0008" src="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Probiotics versus antibiotics in women, Outcome 3 Worst case scenario antibiotics ‐ symptomatic bacterial UTI. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/references#CD008772-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008772-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/urn:x-wiley:14651858:media:CD008772:CD008772-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_t/tCD008772-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Probiotics versus control in children with vesicoureteric reflux, Outcome 1 Symptomatic bacterial UTI." data-id="CD008772-fig-0009" src="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Probiotics versus control in children with vesicoureteric reflux, Outcome 1 Symptomatic bacterial UTI. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/references#CD008772-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008772-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/urn:x-wiley:14651858:media:CD008772:CD008772-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_t/tCD008772-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Worst case scenario imputation ‐ symptomatic bacterial UTI, Outcome 1 Placebo comparison." data-id="CD008772-fig-0010" src="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Worst case scenario imputation ‐ symptomatic bacterial UTI, Outcome 1 Placebo comparison. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/references#CD008772-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008772-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/urn:x-wiley:14651858:media:CD008772:CD008772-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_t/tCD008772-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Worst case scenario imputation ‐ symptomatic bacterial UTI, Outcome 2 Antibiotic comparison ‐ worst case probiotics." data-id="CD008772-fig-0011" src="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Worst case scenario imputation ‐ symptomatic bacterial UTI, Outcome 2 Antibiotic comparison ‐ worst case probiotics. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/references#CD008772-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008772-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/urn:x-wiley:14651858:media:CD008772:CD008772-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_t/tCD008772-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Worst case scenario imputation ‐ symptomatic bacterial UTI, Outcome 3 Antibiotic comparison ‐ worst case antibiotics." data-id="CD008772-fig-0012" src="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Worst case scenario imputation ‐ symptomatic bacterial UTI, Outcome 3 Antibiotic comparison ‐ worst case antibiotics. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/references#CD008772-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/media/CDSR/CD008772/image_n/nCD008772-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD008772-tbl-0001"> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Probiotics compared with placebo or antibiotics for urinary tract infections (UTI)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: adults and children at risk of UTI</b> </p> <p><b>Settings: outpatient</b> </p> <p><b>Intervention: probiotics</b> </p> <p><b>Comparison: placebo or antibiotics</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probiotics</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic bacterial UTI in adults and children in patients with and without recurrent UTI</b> </p> <p><b>Probiotics versus placebo</b> </p> <p>(follow‐up)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>395 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>296 per 1000</b> <br/> (197 to 446) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR</b> 0.75 (0.50, 1.13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>352 (6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk of bias was assessed at unclear or high in most domains and suggest that results are imprecise or overestimate probiotic effects versus placebo </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic bacterial UTI in adults and children with recurrent UTI</b> </p> <p><b>Probiotics versus placebo</b> </p> <p>(follow‐up)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>421 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>315 per 1000</b> <br/> (227 to 425) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR</b> 0.74 (0.54, 1.01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>275 (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk of bias was assessed at unclear or high in most domains and suggest that results are imprecise or overestimate probiotic effects versus placebo </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic bacterial UTI in women with recent UTI</b> </p> <p><b>Probiotics versus antibiotics</b> </p> <p>(follow‐up)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>666 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>745 per 1000</b> <br/> (632 to 885) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR</b> 1.12 (0.95, 1.33) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>223 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk of bias was assessed at unclear or high in most domains and suggest that results are imprecise or overestimate probiotic effects versus antibiotics. </p> <p>Imprecision also due to small sample from only one RCT</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic bacterial UTI in children with VUR</b> </p> <p><b>Probiotics versus placebo</b> </p> <p>(follow‐up)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>270 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>145 per 1000</b> <br/> (64 to 332) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR</b> 0.54 (0.24, 1.23) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Risk of bias was assessed at unclear or high in most domains of and suggest that results are imprecise or overestimate probiotic effects versus placebo. </p> <p>Imprecision also due to small sample from only one RCT</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>UTi ‐ urinary tract infection</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-title"></span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/full#CD008772-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008772-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Probiotics versus placebo in adults and children</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Symptomatic bacterial UTI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>352</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.60, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Versus placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.65, 1.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Versus placebo with recurrent UTI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>275</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.52, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Worst case scenario ‐ symptomatic bacterial UTI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>352</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.63, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Versus placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.71 [0.12, 112.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Versus placebo with recurrent UTI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>275</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.60, 1.19]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Probiotics versus placebo in adults and children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/references#CD008772-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008772-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Probiotics versus antibiotics in women</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Symptomatic bacterial UTI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Versus antibiotics with recent UTI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Worst case scenario probiotics ‐ symptomatic bacterial UTI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Versus antibiotics with recent UTI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Worst case scenario antibiotics ‐ symptomatic bacterial UTI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Versus antibiotics with recent UTI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Probiotics versus antibiotics in women</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/references#CD008772-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008772-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Probiotics versus control in children with vesicoureteric reflux</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Symptomatic bacterial UTI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Probiotics versus control in children with vesicoureteric reflux</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/references#CD008772-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008772-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Worst case scenario imputation ‐ symptomatic bacterial UTI</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Placebo comparison <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>352</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.63, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Versus placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.71 [0.12, 112.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Versus placebo with recurrent UTI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>275</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.60, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Antibiotic comparison ‐ worst case probiotics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Versus antibiotics with recent UTI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Antibiotic comparison ‐ worst case antibiotics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Versus antibiotics with recent UTI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Worst case scenario imputation ‐ symptomatic bacterial UTI</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008772.pub2/references#CD008772-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD008772.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD008772-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD008772-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD008772-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD008772-note-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD008772-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD008772-note-0005">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD008772-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD008772-note-0013">ภาษาไทย</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008772\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008772\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008772\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008772\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008772\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008772\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008772\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008772\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008772\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008772\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008772\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008772\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008772\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008772\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008772\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008772\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008772\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008772\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uQyIsxpV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008772.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008772.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD008772.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD008772.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008772.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726506291"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008772.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726506295"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008772.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e954a4c9ef3c9',t:'MTc0MDcyNjUwNi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 